BioDiscovery Blog

Featured Post

The Secret is out - NxClinical 4.1 is here!

We are excited to announce the release of NxClinical 4.1! Our unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.

Featured Post

Looking back at ACMG 2018

The Annual Clinical Genetics Meeting (ACMG) is soon, we wanted to make sure you didn't miss out on the action down in Charlotte, North Carolina! Visit booth #806 or our exhibit theater with Dr. Sarah Murray, UCSD to learn more about CNV, AOH and Sequence Variants Detected from a Single NGS Assay.

Featured Post

ACMG 2018 in Charlotte is Right Around the Corner! 

The Annual Clinical Genetics Meeting (ACMG) is soon, we wanted to make sure you didn't miss out on the action down in Charlotte, North Carolina! Visit booth #806 or our exhibit theater with Dr. Sarah Murray, UCSD to learn more about CNV, AOH and Sequence Variants Detected from a Single NGS Assay.

Chatting with Dr. Ingrid Simonic about Consolidation of Multiple Testing Strategies

Recently we spoke with Dr. Ingrid Simonic, Deputy Director, Medical Genetics Laboratories, Cambridge University Hospitals, about the current stage of testing strategies, in particular the workflow at her hospital. She discussed how they perform many tests at the hospital and not necessarily because there are that many patients but that several tests are performed per patient.

The Secret is out - NxClinical 4.1 is here!

We are excited to announce the release of NxClinical 4.1! Our unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.

Looking back at ACMG 2018

The Annual Clinical Genetics Meeting (ACMG) is soon, we wanted to make sure you didn't miss out on the action down in Charlotte, North Carolina! Visit booth #806 or our exhibit theater with Dr. Sarah Murray, UCSD to learn more about CNV, AOH and Sequence Variants Detected from a Single NGS Assay.

ACMG 2018 in Charlotte is Right Around the Corner! 

The Annual Clinical Genetics Meeting (ACMG) is soon, we wanted to make sure you didn't miss out on the action down in Charlotte, North Carolina! Visit booth #806 or our exhibit theater with Dr. Sarah Murray, UCSD to learn more about CNV, AOH and Sequence Variants Detected from a Single NGS Assay.

Phenotype risk scores identify patients with unrecognized Mendelian disease patterns

A recent Science article, "Phenotype risk scores identify patients with unrecognized Mendelian disease patterns", from Vanderbilt University Medical Center leverages the phenotypic patterns of Mendelian diseases to detect rare-variant associations and finds that most of the individuals with statistically significant variants were undiagnosed with the target Mendelian disease.

BioDiscovery and Thermo Fisher Scientific Sign OEM Partnership

Recently, BioDiscovery signed an OEM partnership deal with Thermo Fisher Scientific for analysis software for the OncoScan Assay. The partnership allows the two companies to merge their expertise in high-throughput genomic data analysis software and array based assays for the cancer genomics market. BioDiscovery developed Nexus Express for OncoScan software for Thermo Fisher's OncoScan CNV Assay for solid tumor analysis.

The inaugural Southern California Regional Clinical Cytogenetics & Molecular Genetics Meeting was a great success!

Over a dozen of Southern California's finest Cytogenesis and Molecular genesis came together to discuss latest developments, share experiences and information, and help overcome challenges. This proved to be a breeding ground for new ideas, collaborations, and learning.

Does reanalysis improve diagnostic yield?

A recent paper on the project shared results from a reanalysis in 2017 of the initial 1133 children using new knowledge and findings that have accumulated since the initial analysis. The pace at which improvements in genomic data technologies, analysis, and knowledge are moving, the group hypothesized that it is likely that diagnostic yield would increase via the reanalysis. They sought to determine how much of an improvement can be made over time.

NxClinical February track updates

Post ExcerptThis week many new tracks were added to the NxClinical track auto-update system. Below is a detailed description of what was added. CIViC – CIViC is an open access, open source, community-driven web resource for Clinical Interpretation of Variants in Cancer.

ASHG workshop videos

We had a great workshop at ASHG a few months ago. If you were not at the meeting or missed our workshop, you can still view our guest presenters' talks. We launched NxClinical 4.0 at the conference and prior to that we had some customers who got the chance to use it via our Early Access Program. A few of those users share their experiences in using NxClinical 4.0 specifically in the area of combining analysis and interpretation of CNV, SNV, and allelic events within a single software framework where copy number is derived from NGS data.